title: [Clinical use of the ImmunoCyt/uCyt+ and fluorescence in situ hybridisation (FISH) tests for urothelial carcinomas].
abstract: In recent decades years, we have witnessed the propagation and marketing of numerous diagnostic tests capable of detecting, in the urine of patients, the presence of urothelial tumor markers. Among None of the different markers studied to date , no one has been able to meet all the requirements of the ideal marker. We present and discuss below we discuss the results reported in the literature of about two tests approved by the Food and Drug Administration [ImmunoCyt/uCyt+ and Fluorescence In Situ Hybridisation (FISH)], which have been and commercially available for about 10 years., ImmunoCyt/uCyt + and Fluorescence In Situ Hybridisation (FISH).
authors.affiliation: Reparto di Urologia, Ospedale Generale di Bolzano, Bolzano - Italy. mlodde@hotmail.com
authors.forename: Michele
authors.initials: M
authors.lastname: Lodde
authors.forename: Christine
authors.initials: C
authors.lastname: Mian
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000175:diagnosis*; D006801:Humans; D007159:Immunologic Tests; D017404:In Situ Hybridization, Fluorescence; D014571:Urologic Neoplasms / Q000175:diagnosis*